(Q38227090)

31 August 2017

title

Helicobacter pylori: perspectives and time trends (English)

1 reference

Helicobacter pylori infectious disease

31 August 2017

0 references

1 reference

1

Peter Malfertheiner

1 reference

31 August 2017

Alexander Link

2

1 reference

31 August 2017

Michael Selgrad

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

8 July 2014

1 reference

Nature Reviews Gastroenterology & Hepatology

31 August 2017

published in

1 reference

31 August 2017

volume

11

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

628-638

1 reference

Nobel Prize winners Robin Warren and Barry Marshall

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Microbiological aspects of Helicobacter pylori (Campylobacter pylori).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Expression of Helicobacter pylori urease genes in Escherichia coli grown under nitrogen-limiting conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Cloning and genetic characterization of a Helicobacter pylori flagellin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Cytotoxic activity in broth-culture filtrates of Campylobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Duodenal ulcer promoting gene of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The complete genome sequence of the gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Guidelines for treatment of Helicobacter pylori in the East and West

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

t(11;18)(q21;q21.1): a recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Is there a link between the lipopolysaccharide of Helicobacter pylori gastric MALT lymphoma associated strains and lymphoma pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection induces gastric cancer in mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori and gastric cancer: factors that modulate disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Molecular diagnostics in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Oncogenic mechanisms of the Helicobacter pylori CagA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Gastric cancer: epidemiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Molecular pathogenesis of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Relation of Helicobacter pylori infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection and chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori is a risk factor for colonic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori colonization is inversely associated with childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Campylobacter pylori gastritis: long term results of treatment with amoxycillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

[Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Lack of eradication of Helicobacter pylori after omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Metronidazole-resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Role of metronidazole resistance in therapy of Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Development of vaccines against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Amino terminus and the first four membrane-spanning segments of the Arabidopsis K+ channel KAT1 confer inward-rectification property of plant-animal chimeric channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The role of gastrin in ulcer pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Mechanisms of disease: Helicobacter pylori virulence factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Role of Helicobacter pylori eradication in high-grade MALT lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

t(11;18)(q21;q21) is the most common translocation in MALT lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

CagA antigen of helicobacter pylori and coronary instability: Insight from a clinico-pathological study and a meta-analysis of 4241 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori and extragastric diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Helicobacter pylori and metronidazole resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

7 January 2021

Characteristics of Helicobacter pylori variants selected for urease deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

7 January 2021

Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

7 January 2021

Characterization of a Helicobacter pylori neutrophil-activating protein.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

7 January 2021

Factors influencing the eradication of Helicobacter pylori with triple therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.99

7 January 2021

Identifiers

DOI

10.1038/NRGASTRO.2014.99

1 reference

31 August 2017

1 reference